Limosilactobacillus reuteri KUB-AC5 partially attenuates metabolic disturbance but has limited effects on submandibular gland alterations in obese rats

Obese​ insulin resistance (OIR) is associated with submandibular gland pathology, fibrosis, and molecular alterations. Although probiotics have shown protective effects on the gut and other vulnerable organs, their impact on submandibular gland pathology under OIR conditions remains unclear. This study aimed to determine whether administration of the probiotic, Limosilactobacillus reuteri ( formerly Lactobacillus reuteri) KUB-AC5, reduces metabolic disturbance and attenuates submandibular gland pathology in OIR rats. Thirty-two male Wistar rats were acclimated for one week (week 0–1). Thirty male Wistar rats were included in the final analysis, as two rats assigned to the NDV group were excluded before initiation of the experimental protocol. Then, all rats were fed either a normal diet or a high-fat diet for 24 weeks (week 1–25). From week 13, rats were subdivided to receive PBS or Limosilactobacillus reuteri KUB-AC5 (1 × 10⁸ CFU/day in 1 mL of PBS by oral gavage for 12 weeks) until week 25 (week 13–25). Next, metabolic parameters and submandibular gland (SMG) pathology were evaluated. Limosilactobacillus reuteri KUB-AC5 administration reduced body weight and insulin resistance, but did not significantly decrease total cholesterol levels in OIR rats. The high-fat diet-fed rats treated with vehicle (HFV) displayed SMG pathology, characterized by decreased antioxidant levels, altered expression of selected mitochondrial-related genes, elevated proinflammatory cytokine, and increased fibrotic area. At the dose and treatment duration used in the present study, Limosilactobacillus reuteri KUB-AC5 improved selected systemic parameters but was not associated with statistically significant improvements in the major molecular and histological alterations evaluated in the SMG of OIR rats. In conclusion, Limosilactobacillus reuteri KUB-AC5 partially reduced systemic metabolic disturbances in OIR rats. However, these effects were not accompanied by statistically significant improvements in SMG pathology, fibrosis, or associated molecular alterations under the present experimental conditions.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-17
DOI
https://doi.org/10.1038/s41598-026-80039-6
Primary Topic
Probiotics and Fermented Foods
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Limosilactobacillus reuteri KUB-AC5 partially attenuates metabolic disturbance but has limited effects on submandibular gland alterations in obese rats

Nipon Chattipakorn, Titikorn Chunchai, Hiranya Pintana, Siriporn Chaisin Chattipakorn et al.
3 links
Scientific Reports
Probiotics and Fermented Foods
article

Limosilactobacillus reuteri KUB-AC5 partially attenuates metabolic disturbance but has limited effects on submandibular gland alterations in obese rats

Nipon Chattipakorn, Titikorn Chunchai, Hiranya Pintana, Siriporn Chaisin Chattipakorn, Parameth Thiennimitr, Poonsharas Kittikunkanyakit, Pacharapon Wongcharee, Pisuittiwa Prommetjit, Nattapol Aroonsingkarat
article en

Abstract

Obese​ insulin resistance (OIR) is associated with submandibular gland pathology, fibrosis, and molecular alterations. Although probiotics have shown protective effects on the gut and other vulnerable organs, their impact on submandibular gland pathology under OIR conditions remains unclear. This study aimed to determine whether administration of the probiotic, Limosilactobacillus reuteri ( formerly Lactobacillus reuteri) KUB-AC5, reduces metabolic disturbance and attenuates submandibular gland pathology in OIR rats. Thirty-two male Wistar rats were acclimated for one week (week 0–1). Thirty male Wistar rats were included in the final analysis, as two rats assigned to the NDV group were excluded before initiation of the experimental protocol. Then, all rats were fed either a normal diet or a high-fat diet for 24 weeks (week 1–25). From week 13, rats were subdivided to receive PBS or Limosilactobacillus reuteri KUB-AC5 (1 × 10⁸ CFU/day in 1 mL of PBS by oral gavage for 12 weeks) until week 25 (week 13–25). Next, metabolic parameters and submandibular gland (SMG) pathology were evaluated. Limosilactobacillus reuteri KUB-AC5 administration reduced body weight and insulin resistance, but did not significantly decrease total cholesterol levels in OIR rats. The high-fat diet-fed rats treated with vehicle (HFV) displayed SMG pathology, characterized by decreased antioxidant levels, altered expression of selected mitochondrial-related genes, elevated proinflammatory cytokine, and increased fibrotic area. At the dose and treatment duration used in the present study, Limosilactobacillus reuteri KUB-AC5 improved selected systemic parameters but was not associated with statistically significant improvements in the major molecular and histological alterations evaluated in the SMG of OIR rats. In conclusion, Limosilactobacillus reuteri KUB-AC5 partially reduced systemic metabolic disturbances in OIR rats. However, these effects were not accompanied by statistically significant improvements in SMG pathology, fibrosis, or associated molecular alterations under the present experimental conditions.

Scientific Reports
Office of the Royal Society (TH), Chiang Mai University (TH)
Chiang Mai University, Thailand Science Research and Innovation
Good health and well-being
Probiotics and Fermented Foods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon